Page last updated: 2024-08-22

olsalazine and Disease Models, Animal

olsalazine has been researched along with Disease Models, Animal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Hou, T; Li, Y; Liang, X; Lin, H; Liu, F; Otkur, W; Pei, S; Piao, HL; Qi, H; Wang, J; Xiang, K; Yang, R; Zhang, X; Zhou, H1
Tang, M; Xin, WF; Xu, YS; Yu, ZY1
Gao, L; Li, H; Li, L; Li, Q; Lin, H; Niu, Y; Yang, P1
Fitzpatrick, LR; Green, CL; Maines, LW; Smith, CD; Zhuang, Y1
Chang, EB; Hanauer, SB; Kles, KA; Musch, MW; Turner, JR; Vavricka, SR1
Axelsson, LG; Bylund-Fellenius, AC; Landström, E1
Brown, WA; Farmer, KC; Malcontenti-Wilson, C; Misajon, A; O'Brien, PE; Skinner, SA1
Crouch, R; Davis, AE; Patterson, F1
Garrelds, IM; van Dijk, AP; Wilson, JH; Zijlstra, FJ1

Other Studies

9 other study(ies) available for olsalazine and Disease Models, Animal

ArticleYear
Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.
    European journal of pharmacology, 2023, Jun-15, Volume: 949

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; NF-kappa B; Prodrugs; Receptors, G-Protein-Coupled

2023
The effect of olsalazine of chinese generic drugs on ulcerative colitis induced by dextran sulfate sodium salt in BALB/c mice.
    Acta cirurgica brasileira, 2023, Volume: 38

    Topics: Animals; China; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Drugs, Generic; Epidermal Growth Factor; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-2; Interleukin-7; Mice; Mice, Inbred BALB C; Tumor Necrosis Factor-alpha

2023
Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.
    Biological & pharmaceutical bulletin, 2020, Nov-01, Volume: 43, Issue:11

    Topics: Aminosalicylic Acids; Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose Transport Proteins, Facilitative; Humans; Hyperuricemia; Kidney Tubules, Proximal; Male; Mice; Monosaccharide Transport Proteins; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Renal Elimination; Renal Reabsorption; Sodium-Phosphate Cotransporter Proteins, Type I; Uric Acid

2020
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
    Inflammopharmacology, 2010, Volume: 18, Issue:2

    Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Epithelial Cells; Female; Gastrointestinal Agents; Humans; Interleukin-1beta; Leukocytes; Male; Mice; Mice, Inbred C57BL; Neutrophils; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Prednisolone; Pyridines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2010
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
    Inflammatory bowel diseases, 2005, Volume: 11, Issue:3

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Diarrhea; Disease Models, Animal; Gastrointestinal Agents; Ileum; Mesalamine; Phenylhydrazines; Prodrugs; Rabbits; Random Allocation; Sulfasalazine; Tissue Culture Techniques

2005
Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9

    Topics: Aminosalicylic Acids; Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; Mice, Nude; Outcome Assessment, Health Care; Sulfasalazine; Survival Analysis; Treatment Outcome

1998
5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:8

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Colorectal Neoplasms; Disease Models, Animal; Male; Mesalamine; Rats; Rats, Sprague-Dawley

2000
The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.
    British journal of cancer, 1992, Volume: 66, Issue:5

    Topics: Adenocarcinoma; Aminosalicylic Acids; Animals; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Incidence; Inflammatory Bowel Diseases; Male; Mesalamine; Metronidazole; Neoplasm Invasiveness; Rats; Rats, Wistar; Sulfasalazine

1992
Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonic tissue.
    Agents and actions, 1992, Volume: Spec No

    Topics: Aminosalicylic Acids; Animals; Arachidonic Acid; Calcimycin; Carrageenan; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Eicosanoids; Female; Intestinal Mucosa; Mice; Mice, Inbred BALB C

1992